Abstract
With the rapid development of high-throughput genomic technologies and the accumulation of genome-wide datasets for human disease, it has been shown that using only reductionistic principles has been difficult to capture the complex biological networks and design rational medication. However, the emerging paradigm of “network based methodology” proposes to harness the power of networks to uncover relationships between various data types of interest for drug discovery. Recent advances include networks that encompass relationships between drugs, disease-related genes, therapeutic targets and diseases. It is shown how network techniques can help in the investigation of the mechanism of action of existing drugs, new molecules, or to identify novel disease genes and targets. We review how these different types of network analysis approaches facilitate drug discovery and their associated challenges. Some representative examples are reviewed to show that network analysis is a powerful, integrated, computational and experimental approach to improve the drug discovery process.
Keywords: Drug discovery, target identification, network analysis.
Mini-Reviews in Medicinal Chemistry
Title:Network based Approach to Drug Discovery: A Mini Review
Volume: 15 Issue: 8
Author(s): Peng Li, Yingxue Fu and Yonghua Wang
Affiliation:
Keywords: Drug discovery, target identification, network analysis.
Abstract: With the rapid development of high-throughput genomic technologies and the accumulation of genome-wide datasets for human disease, it has been shown that using only reductionistic principles has been difficult to capture the complex biological networks and design rational medication. However, the emerging paradigm of “network based methodology” proposes to harness the power of networks to uncover relationships between various data types of interest for drug discovery. Recent advances include networks that encompass relationships between drugs, disease-related genes, therapeutic targets and diseases. It is shown how network techniques can help in the investigation of the mechanism of action of existing drugs, new molecules, or to identify novel disease genes and targets. We review how these different types of network analysis approaches facilitate drug discovery and their associated challenges. Some representative examples are reviewed to show that network analysis is a powerful, integrated, computational and experimental approach to improve the drug discovery process.
Export Options
About this article
Cite this article as:
Li Peng, Fu Yingxue and Wang Yonghua, Network based Approach to Drug Discovery: A Mini Review, Mini-Reviews in Medicinal Chemistry 2015; 15 (8) . https://dx.doi.org/10.2174/1389557515666150219143933
DOI https://dx.doi.org/10.2174/1389557515666150219143933 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique
Current Pharmaceutical Design Efficacy and Safety of Combined Radiotherapy with EGFR Inhibitors and Chemotherapy for Laryngeal Organ Preservation in Patients with Locally Advanced Hypopharyngeal Carcinomas
Current Cancer Drug Targets Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Current Advances in Retroviral Gene Therapy
Current Gene Therapy Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Therapeutic Monoclonal Antibodies in Clinical Practice against Cancer
Anti-Cancer Agents in Medicinal Chemistry Liposomes as Potential Carrier System for Targeted Delivery of Polyene Antibiotics
Recent Patents on Inflammation & Allergy Drug Discovery Old Drugs-Current Perspectives
Current Pharmacogenomics Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia
Current Gene Therapy Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Current Stem Cell Research & Therapy Novel Preparative Regimens in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design AIDS Related Viruses, their Association with Leukemia, and Raf Signaling
Current HIV Research Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Current Pharmaceutical Biotechnology Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry A Review of Evaluating Hematopoietic Stem Cells Derived from Umbilical Cord Blood's Expansion and Homing
Current Stem Cell Research & Therapy mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry Antitumor Effects of Interferon-Alpha on Cell Growth and Metastasis in Human Nasopharyngeal Carcinoma
Current Cancer Drug Targets Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma
Current Cancer Drug Targets